Georg Martin Haag

6PUBLICATIONS
24CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 16, 2026
Detection of MSI signals from peripheral blood for monitoring response to immune checkpoint blockade therapy in patients with advanced microsatellite-unstable gastrointestinal cancers: A pilot study.

Aysel Ahadova, Lena Bohaumilitzky, Thomas Walle

|Nov 14, 2023
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial.

Sylvie Lorenzen, Thorsten Oliver Götze, Peter Thuss-Patience

|Apr 20, 2022
Outcome and prognostic factors in patients undergoing salvage therapy for recurrent esophagogastric cancer after multimodal treatment.

Leonidas Apostolidis, Kristin Lang, Leila Sisic

|Feb 13, 2022
Burnout among German oncologists: a cross-sectional study in cooperation with the Arbeitsgemeinschaft Internistische Onkologie Quality of Life Working Group.

Madeleine Helaß, Georg Martin Haag, Ulli Simone Bankstahl

|Jul 06, 2021
Preventive effect of sensorimotor exercise and resistance training on chemotherapy-induced peripheral neuropathy: a randomised-controlled trial.

Jana Müller, Markus Weiler, Andreas Schneeweiss

|Dec 01, 2018
Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy.

Georg Martin Haag, Elena Czink, Aysel Ahadova

Pageof 1

Frequent Collaborators

2 joint publications

Aysel Ahadova

1 joint publications

Thomas Schmidt

1 joint publications

Magnus von Knebel Doeberitz

1 joint publications

Jana Müller